Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30007092HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30001285HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30012289HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30007093HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30004635HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30007094HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30015466HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30013971HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30004636HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30007095HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TCGA Plot Options
Drug Information
GeneTOP2A
DrugBank IDDB00218
Drug NameMoxifloxacin
Target IDBE0000742
UniProt IDP11388
Regulation Typeinhibitor
PubMed IDs11752352; 20596674; 20802486
CitationsChen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.@@Reuveni D, Halperin D, Shalit I, Priel E, Fabian I: Moxifloxacin enhances etoposide-induced cytotoxic, apoptotic and anti-topoisomerase II effects in a human colon carcinoma cell line. Int J Oncol. 2010 Aug;37(2):463-71.@@Wohlkonig A, Chan PF, Fosberry AP, Homes P, Huang J, Kranz M, Leydon VR, Miles TJ, Pearson ND, Perera RL, Shillings AJ, Gwynn MN, Bax BD: Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance. Nat Struct Mol Biol. 2010 Sep;17(9):1152-3. doi: 10.1038/nsmb.1892. Epub 2010 Aug 29.
GroupsApproved; Investigational
Direct ClassificationQuinoline carboxylic acids
SMILES[H][C@]12CN(C[C@@]1([H])NCCC2)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1OC)C(O)=O
Pathways
PharmGKBPA450555
ChEMBLCHEMBL32